Oloa

PUSI # Igoa Oloa Fa'amatalaga
CPD111306 7-bromo-2,4,6-trichloro-8-fluoroquinazoline
CPD113109 ARS-1323-Alkyne ARS-1323-alkyne, o se sui-II taga (S-IIP) inhibitor
CPDP801183 VVD-214;RO7589831;VVD-133214 VVD-214 o se WRN helicase lethal allosteric inhibitor.
CPDP801366 Inlexisertib;DCC-3116 O le DCC-3116 o se fa'agata ULK1/2 fa'amalosi tautala.
CPDA601378 Nonylacridine moli
CPD112537 4H-1,3-Dioxolo[4,5-c]pyrrole-4-carboxylic acid,...
CPDP801763 MC3138 MC3138 o se SIRT5 activator filifilia.
CPDP801758 Chk1-IN-6 O le Chk1-IN-6 ose fa'atosina malosi, filifili, ma e mafai ona tu'u gutu ole CHK1 fa'aitaga sui tauva.
CPD113410 NDI-101150 O le NDI-101150 o se inhibitor malosi ma filifili ole HPK1 (hematopoietic progenitor cell kinase 1).
CPDA601453 BMS-986408 O le BMS-986408 o se fa'ailo fa'agata lua DGK α/Zeta.
CPDA601445 AZD0780;EX-A6975;laroprovstatum; laroprovstat PCSK9-IN-12 o se faʻalapotopotoga heteroaromatic. PCSK9-IN-12 o loʻo i ai le sootaga vavalalata mo PCSK9 ma le tau Kd<200 nM. PCSK9-IN-12 e mafai ona faʻaaogaina mo le suʻesuʻeina o le cholesterol metabolism.
CPDA601447 PF07328948 PF-07328948 ose BDK aoga (branched chain ketone dehydrogenase kinase) inhibitor.
CPD112881 (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hy...
CPD108261 LOXO-305;LY 3527727;Pirtobrutinib Pirtobrutinib (LOXO-305) o se mea e sili ona filifilia ma e le o se faʻaogaina o le isi augatupulaga BTK inhibitor e mafai ona faʻalavelaveina suiga eseese o le BTK C481.
CPD115335 Luxdegalutamide; ARV-766 O le Luxdegalutamide (ARV-766) o se polotini e fa'atatau i le hydrolysis e fa'atatau i le chimeric (PROTAC) e fa'atatau i le androgen receptor (AR), lea e mafai ona fa'aleagaina ai mutants e feso'ota'i ma AR.
CPDA601356 iHSP110-33
CPDP800487 TNG462 O le TNG-462 o se fa'aitaga PRMT5 filifilia tautala lelei.
CPDP801649 1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... O le EED ligand 1 o se inhibitor eseese ma aoga e faʻatatau i le EED subunit o le methyltransferase PRC2.
CPDM400208 6,7-Difluoro-4(3H)-quinazolinone
CPDP801752 N-(4-quinolinylcarbonyl)Glycine
CPDM400190 Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz...
CPDP800126 IDE397 (GSK-4362676)
CPDP801185 NST-628 O le NST-628 o le MAPK molecular gel mole faʻatasi ma le faʻaogaina o le paʻu toto-faiʻai, lea e mafai ona faʻalavelaveina le phosphorylation RAF ma le faʻagaoioia MEK.
CPD115153 NX-2127 NX-2127 ose BTK inhibitor tautala lelei.
;

Faafesootai matou

Su'esu'ega

Tala Fou

  • Top 7 Fa'asologa i Su'esu'ega Fa'afoma'i I le 2018

    Top 7 Fa'asologa i Su'esu'ega Fa'afoma'i I...

    O le i ai i lalo o le faʻateleina o le malosi e tauva ai i se luʻitau o le tamaoaiga ma tekinolosi, e tatau i kamupani vailaʻau ma biotech ona faʻaauau pea ona faʻafouina a latou polokalame R&D ina ia tumau i luma ...

  • ARS-1620: O se fa'atosina fou fa'amoemoeina mo KRAS-mutant kanesa

    ARS-1620: O se fa'ailo fou fou mo K...

    E tusa ai ma se suʻesuʻega na lomia i totonu Cell, ua atiaʻe e le au suʻesuʻe se inhibitor faʻapitoa mo KRASG12C ua taʻua o le ARS-1602 lea na faʻaosoina ai le faʻatupuina o le tumo i isumu. "O lenei suʻesuʻega e tuʻuina atu i vivo faʻamaoniga e mafai ona avea mutant KRAS ...

  • E maua e le AstraZeneca le faʻamalosia o tulafono mo vailaʻau oncology

    Ua maua e le AstraZeneca le faamalosia o tulafono mo...

    Na maua e le AstraZeneca se faʻaleleia faʻalua mo lana oncology portfolio i le Aso Lua, ina ua uma ona talia e le US ma Europa tulafono faʻatonutonu talosaga mo ana vailaʻau, o le laasaga muamua lea i le mauaina o le faʻatagaina mo nei vailaʻau. ...

WhatsApp Online Chat!